Efficacy and safety of ipragliflozin as add-on to metformin for type 2 diabetes: a meta-analysis of double-blind randomized controlled trials-Reference-Cited by-同舟云学术

Efficacy and safety of ipragliflozin as add-on to metformin for type 2 diabetes: a meta-analysis of double-blind randomized controlled trials

Published:2019-09-05 Issue:8 Volume:131 Page:578-588
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Chen Weiping¹,Li Pengyun²,Wang Guoqi¹,Chen Yang¹,Wang Bin¹,Chen Mulan¹

Affiliation:

1. Department of Clinical Medicine, Southwest Medical University, Luzhou, Sichuan, China

2. Key Laboratory of Medical Electrophysiology, Ministry of Education, and Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan, China

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2019.1655381

Reference68 articles.

1. Global estimates of the prevalence of diabetes for 2010 and 2030

2. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications

3. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

4. The mechanisms of action of metformin

5. Is there a Role for Sodium Orthovanadate in the Treatment of Diabetes?

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium‐glucose cotransporter‐2 inhibitors for type 2 diabetes mellitus in adults: An overview of 46 systematic reviews;Diabetes, Obesity and Metabolism;2021-07-08

2. Efficacy and Cardiovascular Safety of SGLT2 Inhibitors;Current Drug Safety;2021-06-08

3. Recent Advances on SGLT 2 Inhibitors: Synthetic Approaches, Therapeutic Benefits, and Adverse Events;Successful Drug Discovery;2021-02-26

SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients

;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2020-08